Research programme: CCR2 receptor antagonists - EPIXAlternative Names: EPX-102216
Latest Information Update: 16 Oct 2009
At a glance
- Originator EPIX Pharmaceuticals
- Class Amides; Piperidines
- Mechanism of Action CCR2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Pain